Sean Devlin, PhD

Assistant Attending Biostatistician

Pictured: Sean Devlin

Office Phone




University of Washington

Current Research Interests

Dr. Devlin’s research interests are in the development of adaptive and nonparametric regression methods for cancer research. His dissertation investigated the use of adaptive modeling techniques to characterize how the discriminatory ability of a medical test (biomarker) may depend on key patient attributes. At Memorial Sloan Kettering, he continues to work on how these flexible methods can be used to explore censored survival data.  Dr. Devlin also collaborates with researchers in the Clinical Leukemia, Bone Marrow Transplant, and Myeloma Services in the design and analysis of retrospective and prospective studies.


  1. Diehr P, Lafferty WE, Patrick DL, Downey L, Devlin SM, Standish LJ. Quality of life at the end of life. Health Qual Life Outcomes 2007;5:51. [PubMed Abstract]

  2. Lafferty WE, Tyree PT, Devlin SM, Andersen MR, Diehr PK. Complementary and alternative medicine provider use and expenditures by cancer treatment phase. Am J Manag Care 2008;14:326-34. [PubMed Abstract]

  3. Devlin SM, Diehr PH, Andersen MR, Goff BA, Tyree PT, Lafferty WE. Identification of ovarian cancer symptoms in health insurance claims data. J Womens Health (Larchmt) 2010;19:381-9. [PubMed Abstract]

  4. Klimek VM, Dolezal EK, Tees MT, Devlin SM, Stein K, Romero A, Nimer SD. “Efficacy of Hypomethylating Agents in Therapy-Related Myelodysplastic Syndromes.” Leukemia Research 2012; 83: 1348-8. [PubMed Abstract]

  5. Wang HE, Devlin SM, Sears GK, Vaillancourt C, Morrison LJ, Weisfeldt M, Callaway CW. Regional variations in early and late survival after out-of-hospital cardiac arrest. Resuscitation. 2012; 83:1343-8. [PubMed Abstract]

  6. Perales MA, Goldberg JD, Yuan J, Koehne G, Lechner L, Papadopoulos EB, Young JW, Jakubowski AA, Zaidi B, Gallardo H, Liu C, Rasalan T, Wolchok JD, Croughs T, Morre M,Devlin SM, van den Brink MR. Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation. Blood. 2012 120:4882-91. [PubMed Abstract]

  7. Zamarin D, Giralt S, Landau H, Lendvai N, Lesokhin A, Chung D, Koehne G, Chimento D, Devlin SM, Riedel E, Bhutani M, Babu D, Hassoun H. Patterns of relapse and progression in multiple myeloma patients after auto-SCT: implications for patients’ monitoring after transplantation. Bone Marrow Transplant 2012;  Epub ahead of print, [PubMed Abstract]

My Downloads